I was also at the AGM and from memory ONE shareholder was asking all the questions of the Chairman and the M.D. Under questioning we did get answers. But I think the Directors got the clear understand that shareholders no longer which to be seen but not heard. Transparency.
PLEASE NOTE.
Per AHR announcement dated 3 December Page one Paragraph 3.
SCOPPING STUDY IS ALSO WELL ADVANCE WITH DELIVERY IS EXPECTED PREE CHRISTMAS.
That?s tomorrow.
I assume the directors are reviewing the scoping study prior to release to the market and potential stutters. Key Word DELIVERY.
An update would be great.
AHR Price at posting:
25.5¢ Sentiment: Hold Disclosure: Held
